vs
Side-by-side financial comparison of Legacy Housing Corp (LEGH) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $25.5M, roughly 1.2× Legacy Housing Corp). Legacy Housing Corp runs the higher net margin — 32.2% vs -32.1%, a 64.3% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -30.6%). Legacy Housing Corp produced more free cash flow last quarter ($15.7M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -9.1%).
Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LEGH vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $31.1M |
| Net Profit | $8.2M | $-10.0M |
| Gross Margin | 26.4% | 25.0% |
| Operating Margin | 40.4% | -9.9% |
| Net Margin | 32.2% | -32.1% |
| Revenue YoY | -30.6% | -4.5% |
| Net Profit YoY | -43.5% | -52.0% |
| EPS (diluted) | $0.38 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | — | ||
| Q3 25 | $28.8M | $31.1M | ||
| Q2 25 | $38.4M | — | ||
| Q1 25 | $24.3M | $35.2M | ||
| Q4 24 | $36.7M | $32.6M | ||
| Q3 24 | $30.2M | $24.7M | ||
| Q2 24 | $31.7M | — | ||
| Q1 24 | $30.8M | $35.7M |
| Q4 25 | $8.2M | — | ||
| Q3 25 | $8.6M | $-10.0M | ||
| Q2 25 | $14.7M | — | ||
| Q1 25 | $10.3M | $-14.8M | ||
| Q4 24 | $14.5M | $-6.6M | ||
| Q3 24 | $15.8M | $-16.2M | ||
| Q2 24 | $16.2M | — | ||
| Q1 24 | $15.1M | $15.6M |
| Q4 25 | 26.4% | — | ||
| Q3 25 | 20.2% | 25.0% | ||
| Q2 25 | 32.4% | — | ||
| Q1 25 | 29.2% | 28.0% | ||
| Q4 24 | 27.3% | 34.0% | ||
| Q3 24 | 29.2% | 21.8% | ||
| Q2 24 | 31.9% | — | ||
| Q1 24 | 33.6% | 33.3% |
| Q4 25 | 40.4% | — | ||
| Q3 25 | 33.7% | -9.9% | ||
| Q2 25 | 43.8% | — | ||
| Q1 25 | 47.7% | -25.7% | ||
| Q4 24 | 42.3% | -6.0% | ||
| Q3 24 | 50.8% | -46.9% | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 54.3% | -2.5% |
| Q4 25 | 32.2% | — | ||
| Q3 25 | 30.0% | -32.1% | ||
| Q2 25 | 38.3% | — | ||
| Q1 25 | 42.3% | -42.0% | ||
| Q4 24 | 39.5% | -20.2% | ||
| Q3 24 | 52.4% | -65.7% | ||
| Q2 24 | 51.1% | — | ||
| Q1 24 | 49.1% | 43.8% |
| Q4 25 | $0.38 | — | ||
| Q3 25 | $0.35 | $-0.29 | ||
| Q2 25 | $0.60 | — | ||
| Q1 25 | $0.41 | $-0.47 | ||
| Q4 24 | $0.59 | $-0.25 | ||
| Q3 24 | $0.64 | $-0.53 | ||
| Q2 24 | $0.65 | — | ||
| Q1 24 | $0.60 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $528.6M | $-10.5M |
| Total Assets | $580.3M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | — | ||
| Q3 25 | $13.6M | $18.9M | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $3.4M | $5.4M | ||
| Q4 24 | $1.1M | $9.5M | ||
| Q3 24 | $570.0K | — | ||
| Q2 24 | $60.0K | — | ||
| Q1 24 | $621.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $528.6M | — | ||
| Q3 25 | $521.6M | $-10.5M | ||
| Q2 25 | $512.8M | — | ||
| Q1 25 | $503.7M | $2.2M | ||
| Q4 24 | $494.0M | $15.4M | ||
| Q3 24 | $479.3M | $-3.9M | ||
| Q2 24 | $463.2M | — | ||
| Q1 24 | $450.4M | $17.7M |
| Q4 25 | $580.3M | — | ||
| Q3 25 | $557.9M | $235.2M | ||
| Q2 25 | $552.0M | — | ||
| Q1 25 | $544.6M | $237.7M | ||
| Q4 24 | $534.2M | $255.4M | ||
| Q3 24 | $521.4M | $246.8M | ||
| Q2 24 | $514.9M | — | ||
| Q1 24 | $510.0M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.0M | $1.8M |
| Free Cash FlowOCF − Capex | $15.7M | $25.0K |
| FCF MarginFCF / Revenue | 61.6% | 0.1% |
| Capex IntensityCapex / Revenue | 13.1% | 5.6% |
| Cash ConversionOCF / Net Profit | 2.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.2M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.0M | — | ||
| Q3 25 | $7.2M | $1.8M | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $4.9M | $1.2M | ||
| Q4 24 | $7.9M | $-6.1M | ||
| Q3 24 | $13.8M | $-613.0K | ||
| Q2 24 | $3.5M | — | ||
| Q1 24 | $10.8M | $-1.4M |
| Q4 25 | $15.7M | — | ||
| Q3 25 | $5.1M | $25.0K | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $3.6M | $-4.3M | ||
| Q4 24 | $6.0M | $-8.6M | ||
| Q3 24 | $9.1M | $-4.0M | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $9.9M | $-7.8M |
| Q4 25 | 61.6% | — | ||
| Q3 25 | 17.8% | 0.1% | ||
| Q2 25 | 9.6% | — | ||
| Q1 25 | 15.0% | -12.1% | ||
| Q4 24 | 16.4% | -26.3% | ||
| Q3 24 | 30.2% | -16.3% | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 32.2% | -21.8% |
| Q4 25 | 13.1% | — | ||
| Q3 25 | 7.1% | 5.6% | ||
| Q2 25 | 6.2% | — | ||
| Q1 25 | 5.2% | 15.5% | ||
| Q4 24 | 5.1% | 7.5% | ||
| Q3 24 | 15.6% | 13.9% | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 2.8% | 17.8% |
| Q4 25 | 2.32× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.71× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LEGH
| Commercial Sales | $8.6M | 34% |
| Retail Store Sales | $6.0M | 24% |
| Inventory Finance Sales | $5.0M | 20% |
| Direct Sales | $4.4M | 17% |
| Other | $1.5M | 6% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
